ID   GLRA2_RAT               Reviewed;         452 AA.
AC   P22771; Q91W28;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   02-OCT-2024, entry version 194.
DE   RecName: Full=Glycine receptor subunit alpha-2 {ECO:0000305|PubMed:2176511};
DE   AltName: Full=Glycine receptor strychnine-binding subunit;
DE   Flags: Precursor;
GN   Name=Glra2 {ECO:0000312|RGD:2705};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-2*), FUNCTION, SUBCELLULAR
RP   LOCATION, ACTIVITY REGULATION, DEVELOPMENTAL STAGE, VARIANT GLY-194, AND
RP   CHARACTERIZATION OF VARIANT GLY-194.
RC   TISSUE=Brain;
RX   PubMed=2176511; DOI=10.1016/0896-6273(90)90346-h;
RA   Kuhse J., Schmieden V., Betz H.;
RT   "A single amino acid exchange alters the pharmacology of neonatal rat
RT   glycine receptor subunit.";
RL   Neuron 5:867-873(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-2*), AND DEVELOPMENTAL STAGE.
RC   STRAIN=Wistar; TISSUE=Spinal cord;
RX   PubMed=1707830; DOI=10.1016/0014-5793(91)80383-e;
RA   Akagi H., Hirai K., Hishinuma F.;
RT   "Cloning of a glycine receptor subtype expressed in rat brain and spinal
RT   cord during a specific period of neuronal development.";
RL   FEBS Lett. 281:160-166(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-2* AND ALPHA-2B), AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Brain;
RX   PubMed=1645300; DOI=10.1016/0014-5793(91)80557-j;
RA   Kuhse J., Kuryatov A., Maulet Y., Malosio M.L., Schmieden V., Betz H.;
RT   "Alternative splicing generates two isoforms of the alpha 2 subunit of the
RT   inhibitory glycine receptor.";
RL   FEBS Lett. 283:73-77(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-2*).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Beato M., Groot Kormelink P.J., Colquhoun D., Sivilotti L.G.;
RT   "Concentration dependence of single channel currents through rat
RT   recombinant alpha 1 glycine receptors.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Glycine receptors are ligand-gated chloride channels. Channel
CC       opening is triggered by extracellular glycine. Channel opening is also
CC       triggered by taurine and beta-alanine (PubMed:2176511). Plays a role in
CC       synaptic plasticity. Contributes to the generation of inhibitory
CC       postsynaptic currents, and is involved in the down-regulation of
CC       neuronal excitability. Plays a role in cellular responses to ethanol.
CC       {ECO:0000250|UniProtKB:P23416, ECO:0000269|PubMed:2176511}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823,
CC         ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:2176511};
CC   -!- ACTIVITY REGULATION: Inhibited by strychnine.
CC       {ECO:0000269|PubMed:2176511}.
CC   -!- SUBUNIT: Homopentamer (in vitro). Interacts with GLRB. Heteropentamer
CC       composed of GLRA2 and GLRB. Both homopentamers and heteropentamers form
CC       functional ion channels, but their characteristics are subtly
CC       different. {ECO:0000250|UniProtKB:P23416}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q7TNC8}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q7TNC8}. Synapse {ECO:0000250|UniProtKB:Q7TNC8}.
CC       Cell membrane {ECO:0000269|PubMed:2176511}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P23415}. Cell projection
CC       {ECO:0000250|UniProtKB:Q7TNC8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha-2*;
CC         IsoId=P22771-1; Sequence=Displayed;
CC       Name=Alpha-2B;
CC         IsoId=P22771-2; Sequence=VSP_000083;
CC   -!- DEVELOPMENTAL STAGE: The alpha-2* subunit isoform is present in
CC       neonatal rats, but not in older animals (PubMed:1707830,
CC       PubMed:2176511). Isoform Alpha-2* and isoform Alpha-2B are detected in
CC       embryonic and neonatal brain. At later postnatal stages, isoform Alpha-
CC       2* levels greatly decrease while isoform Alpha-2B is barely detectable
CC       (PubMed:1645300). {ECO:0000269|PubMed:1707830,
CC       ECO:0000269|PubMed:2176511}.
CC   -!- MISCELLANEOUS: The alpha subunit binds strychnine.
CC       {ECO:0000269|PubMed:2176511}.
CC   -!- MISCELLANEOUS: Identical to the human subunit alpha-2, except for 5
CC       substitutions at positions 18, 24, 37, 194 and 404. Substitution at
CC       position 194 (G -> E) accounts for the lower strychnine sensitivity
CC       observed in neonatal rats. {ECO:0000269|PubMed:2176511}.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Glycine receptor (TC 1.A.9.3) subfamily. GLRA2 sub-subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X57281; CAA40549.1; -; mRNA.
DR   EMBL; X61159; CAA43471.1; -; mRNA.
DR   EMBL; AJ310837; CAC35981.1; -; mRNA.
DR   PIR; S14816; S14816.
DR   PIR; S18836; S18836.
DR   RefSeq; NP_036700.1; NM_012568.3.
DR   RefSeq; XP_003752087.1; XM_003752039.4.
DR   RefSeq; XP_017457394.1; XM_017601905.1.
DR   AlphaFoldDB; P22771; -.
DR   SMR; P22771; -.
DR   CORUM; P22771; -.
DR   STRING; 10116.ENSRNOP00000004443; -.
DR   BindingDB; P22771; -.
DR   ChEMBL; CHEMBL2328; -.
DR   GlyCosmos; P22771; 2 sites, No reported glycans.
DR   GlyGen; P22771; 2 sites.
DR   PhosphoSitePlus; P22771; -.
DR   PaxDb; 10116-ENSRNOP00000004426; -.
DR   GeneID; 24397; -.
DR   KEGG; rno:24397; -.
DR   UCSC; RGD:2705; rat. [P22771-1]
DR   AGR; RGD:2705; -.
DR   CTD; 2742; -.
DR   RGD; 2705; Glra2.
DR   eggNOG; KOG3644; Eukaryota.
DR   InParanoid; P22771; -.
DR   OrthoDB; 4265336at2759; -.
DR   PhylomeDB; P22771; -.
DR   TreeFam; TF315453; -.
DR   Reactome; R-RNO-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   PRO; PR:P22771; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0034707; C:chloride channel complex; IEA:UniProtKB-KW.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098690; C:glycinergic synapse; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:1902495; C:transmembrane transporter complex; IBA:GO_Central.
DR   GO; GO:0016934; F:extracellularly glycine-gated chloride channel activity; ISO:RGD.
DR   GO; GO:0016594; F:glycine binding; ISO:RGD.
DR   GO; GO:0022852; F:glycine-gated chloride ion channel activity; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISO:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; ISO:RGD.
DR   GO; GO:0071294; P:cellular response to zinc ion; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:1902476; P:chloride transmembrane transport; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; ISO:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0007416; P:synapse assembly; IEP:RGD.
DR   CDD; cd19009; LGIC_ECD_GlyR_alpha; 1.
DR   CDD; cd19060; LGIC_TM_GlyR_alpha; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1.
DR   InterPro; IPR006028; GABAA/Glycine_rcpt.
DR   InterPro; IPR008127; Glycine_rcpt_A.
DR   InterPro; IPR008129; Glycine_rcpt_A2.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF28; GLYCINE RECEPTOR SUBUNIT ALPHA-2; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00253; GABAARECEPTR.
DR   PRINTS; PR01673; GLYRALPHA.
DR   PRINTS; PR01675; GLYRALPHA2.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Chloride;
KW   Chloride channel; Disulfide bond; Glycoprotein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Metal-binding;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport; Zinc.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..452
FT                   /note="Glycine receptor subunit alpha-2"
FT                   /id="PRO_0000000418"
FT   TOPO_DOM        28..256
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TRANSMEM        257..278
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TOPO_DOM        279..283
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TRANSMEM        284..304
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TOPO_DOM        305..315
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TRANSMEM        316..336
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TOPO_DOM        337..420
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TRANSMEM        421..441
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   TOPO_DOM        442..452
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   BINDING         226
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   BINDING         228
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   BINDING         236..241
FT                   /ligand="strychnine"
FT                   /ligand_id="ChEBI:CHEBI:90700"
FT                   /evidence="ECO:0000250|UniProtKB:O93430"
FT   BINDING         249
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   SITE            194
FT                   /note="Important for glycine and strychnine binding"
FT                   /evidence="ECO:0000305|PubMed:2176511"
FT   SITE            295
FT                   /note="Important for obstruction of the ion pore in the
FT                   closed conformation"
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   CARBOHYD        72
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        103
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        172..186
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   DISULFID        232..243
FT                   /evidence="ECO:0000250|UniProtKB:P23415"
FT   VAR_SEQ         85..86
FT                   /note="VT -> IA (in isoform Alpha-2B)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000083"
FT   VARIANT         194
FT                   /note="E -> G (increased sensitivity to strychnine)"
FT                   /evidence="ECO:0000269|PubMed:2176511"
SQ   SEQUENCE   452 AA;  52053 MW;  A9EBC6D1552A3A1C CRC64;
     MNRQLVNILT ALFAFFLGTN HFREAFCKDH DSRSGKHPSQ TLSPSDFLDK LMGRTSGYDA
     RIRPNFKGPP VNVTCNIFIN SFGSVTETTM DYRVNIFLRQ QWNDSRLAYS EYPDDSLDLD
     PSMLDSIWKP DLFFANEKGA NFHDVTTDNK LLRISKNGKV LYSIRLTLTL SCPMDLKNFP
     MDVQTCTMQL ESFEYTMNDL IFEWLSDGPV QVAEGLTLPQ FILKEEKELG YCTKHYNTGK
     FTCIEVKFHL ERQMGYYLIQ MYIPSLLIVI LSWVSFWINM DAAPARVALG ITTVLTMTTQ
     SSGSRASLPK VSYVKAIDIW MAVCLLFVFA ALLEYAAVNF VSRQHKEFLR LRRRQKRQNK
     EEDVTRESRF NFSGYGMGHC LQVKDGTAVK ATPANPLPQP PKDADAIKKK FVDRAKRIDT
     ISRAAFPLAF LIFNIFYWIT YKIIRHEDVH KK
//
